Skip to main content

Animations

MJFF Publications

7841 - 7850 of 8571 Results
Title
Year
  • Year
  • 2020
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2017
  • Summary Details
    OPEN
    Title: Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-020-0804-9
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus 10398A>G
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-37541-y
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41592-023-01993-x
    Citation Count: 92
  • Summary Details
    OPEN
    Title: Unique functional responses differentially map onto genetic subtypes of dopamine neurons
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-023-01401-9
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease
    Journal Name: npj Regenerative Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41536-023-00311-5
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Whole proteome copy number dataset in primary mouse cortical neurons
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2023.109336
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Chromosomal inversion polymorphisms shape human brain morphology
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.112896
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Subcellular and regional localization of mRNA translation in midbrain dopamine neurons
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Patterns of grey matter loss associated with motor subscores in early Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.11.009
    Citation Count: 62
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.